630 POSTER Results of a phase 2 study of HGS-ETR1, a fully human agonistic monoclonal antibody to TRAIL Receptor 1, in subjects with relapsed or refractory colorectal cancer (CRC)

A phase 2 study of NEO-102 (ensituximab), a novel chimeric monoclonal antibody, in adult patients (pts) with unresectable, metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.3080 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 3080-3080

Author(s):

Richard D. Kim ◽

Nilofer Saba Azad ◽

Michael Morse ◽

Benjamin R. Tan ◽

Elizabeth Poplin ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Unresectable Metastatic Colorectal Cancer

Adult Patients ◽

Phase 2 ◽

Chimeric Monoclonal Antibody ◽

Phase 2 Study ◽

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2007.12.011 ◽

2008 ◽

Vol 61 (1) ◽

pp. 82-90 ◽

Cited By ~ 114

Author(s):

F. Anthony Greco ◽

Philip Bonomi ◽

Jeffrey Crawford ◽

Karen Kelly ◽

Yun Oh ◽

...

Keyword(s):

Lung Cancer ◽

Monoclonal Antibody ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Trail Receptor ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)

Cancer ◽

10.1002/cncr.30967 ◽

2017 ◽

Vol 124 (4) ◽

pp. 688-697

Author(s):

Neal J. Meropol ◽

Yang Feng ◽

Jean L. Grem ◽

Mary F. Mulcahy ◽

Paul J. Catalano ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Research ◽

Thymidylate Synthase ◽

Research Group ◽

Treatment Selection ◽

Phase 2 ◽

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

Investigational New Drugs ◽

10.1007/s10637-012-9869-8 ◽

2012 ◽

Vol 31 (3) ◽

pp. 760-768 ◽

Cited By ~ 143

Author(s):

Kenneth J. Pienta ◽

Jean-Pascal Machiels ◽

Dirk Schrijvers ◽

Boris Alekseev ◽

Mikhail Shkolnik ◽

...

Keyword(s):

Prostate Cancer ◽

Monoclonal Antibody ◽

Human Monoclonal Antibody ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Phase 2 Study ◽

Chemokine Ligand ◽

Cc Chemokine Ligand 2 ◽

Chemokine Ligand 2

PURE01: An open label, single-arm, phase 2 study of the anti-programmed death (PD)-1 monoclonal antibody (moAb) pembrolizumab for neoadjuvant therapy of muscle-invasive urothelial bladder carcinoma (miUBC)

Annals of Oncology ◽

10.1093/annonc/mdw373.74 ◽

2016 ◽

Vol 27 ◽

pp. vi294

Author(s):

A. Necchi ◽

L. Mariani ◽

A. Anichini ◽

P. Giannatempo ◽

D. Raggi ◽

...

Keyword(s):

Monoclonal Antibody ◽

Neoadjuvant Therapy ◽

Bladder Carcinoma ◽

Phase 2 ◽

Open Label ◽

Urothelial Bladder Carcinoma ◽

Programmed Death ◽

Phase 2 Study ◽

Urothelial Bladder ◽

Muscle Invasive

OP0224 RESULTS OF A PHASE 2 STUDY OF RG6125, AN ANTI-CADHERIN-11 MONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO ANTI-TNFALPHA THERAPY

10.1136/annrheumdis-2019-eular.3028 ◽

2019 ◽

Cited By ~ 1

Author(s):

Rebecca Finch ◽

Alexandre Sostelly ◽

Kim Sue-Ling ◽

Angela Blaeuer ◽

Guillemette Duchateau-Nguyen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Inadequate Response ◽

Phase 2 ◽

P-273 Hepatectomy followed by adjuvant chemotherapy with capecitabine plus oxaliplatin for three months for liver metastases from colorectal cancer: a multicenter phase 2 study

Annals of Oncology ◽

10.1093/annonc/mdw199.263 ◽

2016 ◽

Vol 27 ◽

pp. ii79

Author(s):

Satake Hironaga ◽

Tsuji Akihito ◽

Hashida Hiroki ◽

Tanioka Hiroaki ◽

Miyake Yasuhiro ◽

...

Keyword(s):

Colorectal Cancer ◽

Adjuvant Chemotherapy ◽

Liver Metastases ◽

Phase 2 ◽

Multicenter Phase ◽

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer

Cancer Medicine ◽

10.1002/cam4.2763 ◽

2019 ◽

Vol 9 (4) ◽

pp. 1485-1494 ◽

Cited By ~ 4

Author(s):

Mark Yarchoan ◽

Chiung‐Yu Huang ◽

Qingfeng Zhu ◽

Anna K. Ferguson ◽

Jennifer N. Durham ◽

...

Keyword(s):

Colorectal Cancer ◽

Mismatch Repair ◽

Advanced Colorectal Cancer ◽

Phase 2 ◽

Abstract 4461: Analysis of circulating tumor DNA (ctDNA) identifies on-treatment genomic alterations in a phase 2 study of veliparib plus FOLFIRI ± bevacizumab vs. placebo plus FOLFIRI ± bevacizumab in metastatic colorectal cancer (mCRC)

10.1158/1538-7445.sabcs18-4461 ◽

2019 ◽

Author(s):

Cyril Y. Ramathal ◽

Erin Murphy ◽

Elizabeth Asque ◽

Arne Jason Grundstad ◽

Peter Ansell ◽

...

Keyword(s):

Colorectal Cancer ◽

Circulating Tumor Dna ◽

Phase 2 ◽

Genomic Alterations ◽

Phase 2 Study ◽

Tumor Dna

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

British Journal of Cancer ◽

10.1038/s41416-019-0537-z ◽

2019 ◽

Vol 121 (5) ◽

pp. 378-383 ◽

Cited By ~ 1

Author(s):

Elena Elez ◽

Carles Pericay ◽

Manuel Valladares-Ayerbes ◽

Inmaculada Bando ◽

Maria Jose Safont ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Salvage Therapy ◽

Phase 2 ◽

Wild Type ◽

Exon 2 ◽

Phase 2 Study ◽

Colorectal Cancer Patients ◽

Kras Exon